LX-102(linxcell)

N/A

Report date: 2024/04/12 16:24:37

Base Information

Drug NameLX-102(linxcell)
Drug Alias NameLX-102(linxcell)LX102(linxcell)
ClassificationCell and gene therapy > Cell therapy
Mechanisms of ActionClaudin 18 protein modulators
TargetsClaudin-18 splice variant 2
Therapy Area/IndicationsGastrointestinal Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesBeijing Lingxin Borui Biotechnology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBeijing Lingxin Borui Biotechnology Co Ltd
Inactive CompaniesN/A
Active IndicationsGastrointestinal Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A